Scientists have identified a pair of neutralizing antibodies - isolated from a patient who recovered from COVID-19 - that bind to the glycoprotein spike of the SARS-CoV-2 virus, blocking the spike's ability to bind to the human ACE2 receptor and mediate viral entry into host cells.
Preliminary tests of the two antibodies in a mouse model resulted in a reduction of virus titers, suggesting that the antibodies may offer therapeutic benefits - in addition to informing the design of small molecule therapeutics and vaccine candidates to fight COVID-19.
The researchers found that the antibodies, named B38 and H4, can each bind simultaneously to different epitopes on the spike's receptor binding domain (RBD), such that both antibodies together may confer a stronger neutralizing effect than either antibody on its own - a prediction supported by in vitro experiments.
This feature also means that, should one of the viral epitopes mutate in a way that prevents the binding of one of the two antibodies (a phenomenon known as immune escape), the other antibody may yet retain its neutralizing activity.
By imaging the structure of the viral spike's RBD bound to B38, the authors confirmed that B38 binds to a subset of the amino acids bound by ACE2 in the RBD, providing an explanation for why B38 confers such strong neutralizing effects.
The authors suggest that a "cocktail" containing both antibodies could provide direct therapeutic benefits for COVID-19 patients, while the new information regarding the viral spike epitopes could aid the development of small molecule antivirals and vaccine candidates to fight the SARS-CoV-2 virus.
https://science.sciencemag.org/content/early/2020/05/12/science.abc2241
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fa-noncompeting-pair-of&filter=22
Twin antibodies show neutralizing activity against SARS-CoV-2
- 1,388 views
- Added
Edited
Latest News
A trial HIV vaccine trigger…
By newseditor
Posted 19 May
AI to predict DNA methylati…
By newseditor
Posted 19 May
Hyperactive platelets from…
By newseditor
Posted 19 May
Chromatin and RNA interacti…
By newseditor
Posted 18 May
Why patients with ARID1A mu…
By newseditor
Posted 18 May
Other Top Stories
SARS-CoV-2 microRNA-like small RNA that represses host genes
Read more
Experimental mRNA HIV vaccine safe, shows promise in animals
Read more
How the bacterial endotoxin LPS prevents or promotes allergic disease
Read more
Genetic mechanism enables bacterial communities to organize into so…
Read more
How gut microbiota triggers inflammation from toothpaste compound t…
Read more
Protocols
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Publications
Vaccine induction of hetero…
By newseditor
Posted 19 May
Brain border-associated mac…
By newseditor
Posted 19 May
Inhibition of fatty acid up…
By newseditor
Posted 19 May
A microglial activation cas…
By newseditor
Posted 19 May
An age-progressive platelet…
By newseditor
Posted 19 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar